The Fraunhofer-Gesellschaft, based in Germany, is one of the world’s leading applied research organizations. It plays a crucial role in the innovation process by prioritizing research in key future technologies and transferring its research findings to industry in order to strengthen Germany as a hub of industrial activity as well as for the benefit of society.
The Fraunhofer IGB is one of the 76 institutes and research centers of the Fraunhofer Society ( www.fraunhofer.de ). Fraunhofer is the world's leading organization for application-oriented research. Approximately 32,000 employees work on an annual research volume of 3.4 billion euros.
At the Fraunhofer Institute of Interfacial and Biochemical Engineering IGB, we combine biology and technology in our business areas Health, Sustainable Chemistry, and Environmental and Climate protection. We develop processes, technologies and products that enable the industrial application of new solutions for patient-centred healthcare, a sustainable bioeconomy as well as a climate-neutral and resource-efficient circular economy. At our locations in Stuttgart, Leuna, Straubing, and Biberach we carry out research in close collaboration with numerous universities in Germany and abroad.
The department of Cell and Tissue Technologies is located in the main institute in Stuttgart and focuses on animal-free in vitro test alternatives. The New Approach Methodologies (NAMs), for the preclinical testing of efficacy and toxicity of substances, has enormous potential for applied research. The department has been working in the field of cell and molecular biology for more than 25 years and has extensive expertise in the genetic modification of cells and the development of genetically modified cell lines as well as in the establishment of complex tissues e.g., human in vitro skin models. The department's portfolio includes its own and patented 2D in vitro test and screening systems as well as various skin models and disease models of the skin. Of course, the department is also involved in the differentiation of organoids from hiPSC and the establishment of different spheroids.
Was Sie bei uns tun
The position is initially available for two years, starting July 1st 2025, with a view to long-term collaboration.
The weekly working time is 39 hours. This position is also available on a part-time basis, Minimum working time share of 75%. We value and promote the diversity of our employees' skills and therefore welcome all applications - regardless of age, gender, nationality, ethnic and social origin, religion, ideology, disability, sexual orientation and identity. Severely disabled persons are given preference in the event of equal suitability. Appointment, remuneration and social security benefits based on the public-sector collective wage agreement (TVöD). Additionally Fraunhofer may grant performance-based variable remuneration components.
With its focus on developing key technologies that are vital for the future and enabling the commercial utilization of this work by business and industry, Fraunhofer plays a central role in the innovation process. As a pioneer and catalyst for groundbreaking developments and scientific excellence, Fraunhofer helps shape society now and in the future.
Interested? Apply online now. We look forward to getting to know you!
If you have any questions about the application process or the position, please contact the HR department:
bewerbung@igb.fraunhofer.de
+49 711 970 4009
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB
www.igb.fraunhofer.de
Kennziffer: 78984 Bewerbungsfrist: 30.04.2025